Top compounds associated with response to USP17L8


Feature Type Standardized
Nominal ANOVA
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.019 0.6
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.6
mRNA ifosfamide CTRPv2 pan-cancer AAC 0.027 0.6
mRNA CIL56 CTRPv2 pan-cancer AAC 0.023 0.6
mRNA prochlorperazine CTRPv2 pan-cancer AAC -0.019 0.6
mRNA BRD-K85133207 CTRPv2 pan-cancer AAC 0.019 0.6
mRNA navitoclax:MST-312 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.018 0.6
mRNA TGX221 CTRPv2 pan-cancer AAC -0.019 0.6
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.017 0.6
mRNA Nilotinib CTRPv2 pan-cancer AAC -0.018 0.6
Download CSV